Heart Failure Therapies following Acute Coronary Syndromes with Reduced Ejection Fraction: Data from the ACSIS Survey.
Barak ZafrirTal OvdatMahmood Abu AkelFadel BahouthKatia OrvinRoy BeigelOffer AmirGabby Elbaz-GreenerPublished in: Journal of personalized medicine (2023)
In current clinical practice, the majority of patients with reduced and mildly-reduced LVEF are treated by ACEI/ARB and beta-blockers early following ACS, whereas MRA is underutilized and the adoption of SGLT2I and ARNI is low. A greater number of therapeutic classes was not associated with reduced short-term rehospitalizations or mortality.
Keyphrases
- acute coronary syndrome
- heart failure
- clinical practice
- electronic health record
- percutaneous coronary intervention
- cross sectional
- left ventricular
- cardiovascular events
- big data
- magnetic resonance
- angiotensin converting enzyme
- atrial fibrillation
- computed tomography
- machine learning
- coronary artery disease
- angiotensin ii